CSIMarket Company Name, Ticker, Competitors, else..
 
Intelligent Bio Solutions Inc   (NASDAQ: INBS)
Other Ticker:  
 
 
Price: $1.7000 $-0.08 -4.494%
Day's High: $1.81 Week Perf: -1.16 %
Day's Low: $ 1.70 30 Day Perf: 18.88 %
Volume (M): 147 52 Wk High: $ 3.00
Volume (M$): $ 250 52 Wk Avg: $1.59
Open: $1.76 52 Wk Low: $1.00



 Market Capitalization (Millions $) 10
 Shares Outstanding (Millions) 6
 Employees 19
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) -7
 Capital Exp. (TTM) (Millions $) 0

Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc is a company that specializes in developing intelligent solutions for the biological sciences field. They focus on creating innovative technologies and software to enhance research and analysis processes in various areas such as genomics, proteomics, and bioinformatics. Their products aim to improve efficiency, accuracy, and productivity in scientific research, aiding researchers in their quest to understand biological systems and develop new treatments and therapies. The company is committed to staying at the forefront of technological advancements and partnering with academic institutions and organizations to drive advancements in the biological sciences.


   Company Address: 135 West, 41ST Street New York 10036 NY
   Company Phone Number: 828-8258   Stock Exchange / Ticker: NASDAQ INBS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX        3.1% 
BJDX        0.62% 
DXCM   -3.94%    
OSUR        2.33% 
UBI        2.33% 
ABT        0.04% 
• View Complete Report
   



Shares

Bio Solutions Inc. Secures $3 Million in Public Offering Boosting Market Confidence

Published Fri, Feb 21 2025 9:05 PM UTC

In the ever-evolving world of medical technology, Intelligent Bio Solutions Inc. (Nasdaq: INBS) has taken a strategic step forward by successfully concluding its $3.0 million public offering of common stock. The New York-based company, known for its innovative, rapid, and non-invasive testing solutions, announced the closing of this financial milestone on February 21, 2025. ...
Shares

Bio Solutions New Public Offering: A Step Towards Growth Amidst Stock Restructuring

Published Wed, Feb 19 2025 9:42 PM UTC

In a press release dated February 19, 2025, Intelligent Bio Solutions Inc. (Nasdaq: INBS) announced its intention to commence an underwritten public offering of shares of its common stock. As a leading entity in the medical technology sphere, the company specializes in rapid, non-invasive testing solutions. However, the press release indicated that the offering s completion,...
Product Service News

Breaking Barriers How Bio Solutions is Transforming Global Drug Screening through Multilingual Innovation,

Published Fri, Jan 31 2025 6:19 PM UTC

Intelligent Bio Solutions: Pioneering a Global Approach to Drug Screening In an era marked by rapid technological advancements and an increasingly interconnected world, Intelligent Bio Solutions Inc (INBS) is at the forefront of a movement that seeks to transcend linguistic barriers. Through its revolutionary upgrade, the INBS Drug Screening System is set to become a truly g...
Clinical Study

Pioneering Precision Bio Solutions Makes Strides in Drug Screening Accuracy and FDA Submission Readiness

Published Tue, Nov 26 2024 1:30 PM UTC

In an era where technological innovation intersects with healthcare, Intelligent Bio Solutions (IBS) has made significant waves in the field of drug screening. Recently, the company achieved a remarkable 94.1% accuracy in its method comparison study, coinciding with favorable pharmacokinetic (PK) study results. Furthermore, the Intelligent Fingerprinting Drug Screening Syste...
Clinical Study

Bio Solutions Advances in Fingerprint Sweat Drug Detection Amidst Financial Challenges,

Published Wed, Nov 13 2024 1:30 PM UTC

The Promises and Challenges of Intelligent Bio Solutions Fingerprint Sweat Drug Detection Technology The healthcare industry is continuously evolving, with innovative technologies emerging that promise to enhance drug detection methods. Recently, Intelligent Bio Solutions Inc. announced positive results from its pharmacokinetic (PK) study, marking a significant step towards...






Intelligent Bio Solutions Inc's Segments
Sales of Goods Cartidges    60.65 % of total Revenue
Sales of Goods Readers    22.75 % of total Revenue
Other Sales    16.61 % of total Revenue
UNITED KINGDOM    94.96 % of total Revenue
AUSTRALIA    0.72 % of total Revenue
Other Country    4.31 % of total Revenue
IFPG    107.13 % of total Revenue
IFPG UNITED KINGDOM    94.96 % of total Revenue
IFPG AUSTRALIA    0.72 % of total Revenue
IFPG Other Country    4.31 % of total Revenue
Biosensor Platform Technology    16.64 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com